Roger Moody

Roger Moody has joined Clinical Genomics as chief financial officer. He will direct the firm's strategic and tactical financial operations. Moody had been CEO of GlySure, where he remains a director. Prior to that, he was CFO at Nanosphere; executive VP, managing director, and COO at Indegene; and CFO at Medsn before that firm was acquired by Indegene.


Ann Rhoads

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.